Ticker Scorecard - EDIT Basics Company: Editas Medicine, Inc. IPO Date: February 3, 2016 Sector: Healthcare Industry: Biotech Market Cap: $99.88M Activated in VL: True Average Daily Range Avg Daily Range: $0.75 | 3.23% Avg Daily Range (30 D): $0.07 | 4.41% Avg Daily Range (90 D): $0.09 | 3.64% Institutional Daily Volume Avg Daily Volume: 1.17M Avg Daily Volume (30 D): 2.73M Avg Daily Volume (90 D): 2.18M Trade Size Avg Trade Size (Sh.): 100 Avg Trade Size (Sh.) (30 D): 276 Avg Trade Size (Sh.) (90 D): 188 Institutional Trades Total Inst.Trades: 3,784 Avg Inst. Trade: $2.01M Avg Inst. Trade (30 D): $.91M Avg Inst. Trade (90 D): $1.79M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.8M Avg Closing Trade (30 D): $1.07M Avg Closing Trade (90 D): $2.19M Avg Closing Volume: 159.08K     News Sep 10, 2024 @ 8:51 AM Gene Editing Therapeutics Market Forecast 2024-202... Source: Researchandmarkets.Com Aug 30, 2024 @ 12:59 PM Gene Therapy Market Size to Reach USD 54.39 Billio... Source: Sns Insider Aug 28, 2024 @ 1:00 PM Editas Medicine to Participate in Upcoming Investo... Source: N/A Jun 17, 2024 @ 12:13 PM Editas (EDIT) Reports Upbeat New Data From Reni-Ce... Source: Zacks Equity Research Jun 14, 2024 @ 7:01 AM Editas Medicine Reports New Safety and Efficacy Da... Source: Editas Medicine, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.54 $-.75 $-.82 Diluted EPS $-2.54 $-.75 $-.82 Revenue $ 61.76M $ .06M $ .51M Gross Profit $ $ $ Net Income / Loss $ -210.57M $ -62.14M $ -67.61M Operating Income / Loss $ -228.52M $ -65.67M $ -71.9M Cost of Revenue $ $ $ Net Cash Flow $ 13.29M $ 31.39M $ -4.79M PE Ratio